Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (591-600 of 717) with videos related to

Pageof 72
Sort By:
The American Journal of Cardiology|June 18, 2021
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 YearsHikari Seki, Hidehiro Kaneko, Hiroyuki Morita, et al.
Cardiovascular Diabetology|September 15, 2016
Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE studyTatsuya Maruhashi, Yukihito Higashi, Yasuki Kihara, et al.
European Heart Journal Open|August 3, 2022
Relationship of normal-weight central obesity with the risk for heart failure and atrial fibrillation: analysis of a nationwide health check-up and claims databaseKensuke Ueno, Hidehiro Kaneko, Kentaro Kamiya, et al.
Circulation. Population Health and Outcomes|April 27, 2026
Impact of Cardiovascular-Kidney-Metabolic Syndrome on Cancer Development: Insights From a Nationwide Database StudyTatsuhiko Azegami, Hidehiro Kaneko, Yuta Suzuki, et al.
Circulation Reports|July 12, 2021
Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort StudyNaofumi Yoshida, Sachiyo Iwata, Masato Ogawa, et al.
American Heart Journal|July 25, 2022
Glycemic status and the association of change in blood pressure with incident cardiovascular diseaseYuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, et al.
The American Journal of Cardiology|June 30, 2022
Age-Specific Relation of Cardiovascular Health Metrics With Incident Cardiovascular DiseaseHidetaka Itoh, Hidehiro Kaneko, Akira Okada, et al.
Diabetes, Obesity & Metabolism|January 23, 2026
SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 1, 2020
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists - Systematic Literature Review and Additional AnalysisTadafumi Sugimoto, Atsushi Mizuno, Takuya Kishi, et al.
Journal of Diabetes Investigation|June 16, 2020
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.
Pageof 72

Showing results (591-600 of 717) with videos related to

Sort By:
Pageof 72
The American Journal of Cardiology|June 18, 2021
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 YearsHikari Seki, Hidehiro Kaneko, Hiroyuki Morita, et al.
Cardiovascular Diabetology|September 15, 2016
Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE studyTatsuya Maruhashi, Yukihito Higashi, Yasuki Kihara, et al.
European Heart Journal Open|August 3, 2022
Relationship of normal-weight central obesity with the risk for heart failure and atrial fibrillation: analysis of a nationwide health check-up and claims databaseKensuke Ueno, Hidehiro Kaneko, Kentaro Kamiya, et al.
Circulation. Population Health and Outcomes|April 27, 2026
Impact of Cardiovascular-Kidney-Metabolic Syndrome on Cancer Development: Insights From a Nationwide Database StudyTatsuhiko Azegami, Hidehiro Kaneko, Yuta Suzuki, et al.
Circulation Reports|July 12, 2021
Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors - Insights From a Nationwide Japanese Cohort StudyNaofumi Yoshida, Sachiyo Iwata, Masato Ogawa, et al.
American Heart Journal|July 25, 2022
Glycemic status and the association of change in blood pressure with incident cardiovascular diseaseYuta Suzuki, Hidehiro Kaneko, Yuichiro Yano, et al.
The American Journal of Cardiology|June 30, 2022
Age-Specific Relation of Cardiovascular Health Metrics With Incident Cardiovascular DiseaseHidetaka Itoh, Hidehiro Kaneko, Akira Okada, et al.
Diabetes, Obesity & Metabolism|January 23, 2026
SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation studyTatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 1, 2020
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists - Systematic Literature Review and Additional AnalysisTadafumi Sugimoto, Atsushi Mizuno, Takuya Kishi, et al.
Journal of Diabetes Investigation|June 16, 2020
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.
Pageof 72